NMC

NEA Management Company Portfolio holdings

AUM $1.33B
This Quarter Return
-3.06%
1 Year Return
+85.82%
3 Year Return
+531.37%
5 Year Return
+304.32%
10 Year Return
+4,927.96%
AUM
$1.91B
AUM Growth
+$1.91B
Cap. Flow
+$67.9M
Cap. Flow %
3.55%
Top 10 Hldgs %
65.78%
Holding
51
New
4
Increased
5
Reduced
2
Closed
1

Top Buys

1
BDTX icon
Black Diamond Therapeutics
BDTX
$86.1M
2
ELVN icon
Enliven Therapeutics
ELVN
$64.4M
3
CSPR
Casper Sleep Inc.
CSPR
$26.7M
4
TRIL
Trillium Therapeutics Inc.
TRIL
$14.7M
5
LUMO
Lumos Pharma, Inc. Common Stock
LUMO
$4.48M

Top Sells

1
AVEO
AVEO Pharmaceuticals, Inc.
AVEO
$82.2M
2
DERM
Dermira, Inc.
DERM
$53.2M
3
SENS icon
Senseonics Holdings
SENS
$710K

Sector Composition

1 Healthcare 83.31%
2 Technology 13.71%
3 Consumer Discretionary 1.4%
4 Industrials 0.36%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
RARX
1
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
$295M 15.4% 6,138,797 – –
OYST
2
DELISTED
Oyster Point Pharma, Inc. Common Stock
OYST
$207M 10.84% 5,925,287 – –
SPT icon
3
Sprout Social
SPT
$929M
$144M 7.54% 9,046,080 – –
ALLK
4
DELISTED
Allakos
ALLK
$101M 5.27% 2,268,188 – –
NET icon
5
Cloudflare
NET
$72.7B
$95.3M 4.98% 4,059,376 – –
ARDX icon
6
Ardelyx
ARDX
$1.53B
$91.7M 4.79% 16,135,047 – –
CRSP icon
7
CRISPR Therapeutics
CRSP
$4.71B
$88.7M 4.63% 2,090,678 – –
BDTX icon
8
Black Diamond Therapeutics
BDTX
$157M
$86.1M 4.5% +3,449,845 New +$86.1M
AUPH icon
9
Aurinia Pharmaceuticals
AUPH
$1.58B
$75.1M 3.92% 5,172,683 – –
RYTM icon
10
Rhythm Pharmaceuticals
RYTM
$6.85B
$74.8M 3.91% 4,912,306 – –
MRSN icon
11
Mersana Therapeutics
MRSN
$36.5M
$69.7M 3.64% 11,963,649 – –
EPZM
12
DELISTED
Epizyme, Inc
EPZM
$67.9M 3.55% 4,377,518 – –
ELVN icon
13
Enliven Therapeutics
ELVN
$1.2B
$64.4M 3.36% +4,017,170 New +$64.4M
MIRM icon
14
Mirum Pharmaceuticals
MIRM
$3.71B
$58.6M 3.06% 4,187,801 – –
ADAP
15
Adaptimmune Therapeutics
ADAP
$15.6M
$46.5M 2.43% 17,082,611 +1,250,000 +8% +$3.4M
GRTX
16
DELISTED
Galera Therapeutics, Inc. Common Stock
GRTX
$41.4M 2.17% 4,362,986 – –
CSPR
17
DELISTED
Casper Sleep Inc.
CSPR
$26.7M 1.4% +6,226,040 New +$26.7M
TRIL
18
DELISTED
Trillium Therapeutics Inc.
TRIL
$23.2M 1.21% 5,736,363 +3,636,363 +173% +$14.7M
PHAS
19
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
$22M 1.15% 6,643,704 – –
CBIO
20
Crescent Biopharma, Inc. Common Stock
CBIO
$200M
$20.7M 1.08% 9,089,041 – –
SENS icon
21
Senseonics Holdings
SENS
$374M
$18.8M 0.98% 29,761,683 -1,126,583 -4% -$710K
TRVI icon
22
Trevi Therapeutics
TRVI
$883M
$14.6M 0.76% 4,441,360 – –
MEIP icon
23
MEI Pharma
MEIP
$160M
$13.7M 0.72% 8,533,072 – –
CSBR icon
24
Champions Oncology
CSBR
$93.8M
$12.7M 0.66% 1,713,720 +151,220 +10% +$1.12M
GNCA
25
DELISTED
Genocea Biosciences, Inc.
GNCA
$12.4M 0.65% 7,225,676 – –
1
2 3